The Journal of Clinical Pharmacology · 1976 · 21 citations · 7 references
MedicinePharmacologyPharmacotherapyPain ManagementPain MedicinePharmacodynamicsAnalgesiaAnalgesic PharmacologyPharmacologic Pain TherapyAnalgesic Effectiveness EvaluationAnalgesic EffectsClinical Trials Of AnalgesicsDouble-blind TrialsPharmacologic AnalgesiaPharmacologic Management Of PainPharmacologic Pain TreatmentPharmacological Pain Relief
The results of a controlled, double-blind clinical trial are reported demonstrating the potency of analgesia produced by orally and parenterally administered nefopam HCl in hospitalized patients with pain principally of skeletal and neuromuscular origin. The drug is an analogue of orphenadrine, consisting of a cyclization of the diphenhydramine molecule. A double-blind, crossover study was made of the analgesic effects of intramuscular doses of 20 mg nefopam HCl, 50 mg pethidine, and saline placebo in 20 patients. Nefopam and pethidine were found to be equally effective and statistically superior to placebo. A double-blind, randomized study was made of orally administered nefopam HCl, 60 mg t.i.d., for three days and of placebo t.i.d. for three days in 80 patients. Nefopam was distinctly superior to placebo in analgesic effectiveness, both in the initial single dose and in maintaining therapeutic benefit for the duration of the three-day trial. It was concluded that nefopam is a potent analgesic of novel structure and unique physiologic properties.
7
New Developments in Electromyography and Clinical Neurophysiology.
Archives of Neurology · 1974 · 1.6K citations
Benzoxazocines: a new chemical class of centrally acting skeletal muscle relaxants.
M. W. Klohs, Michael Draper, F. J. Petracek et al. · PubMed · 1972 · 28 citations
Nefopam hydrochloride for pain relief.